government | Khurana and Khurana

Protection of Small and Medium Enterprises in UK

28th November, 2022 - 7:41 am Categories: Protection of SMEs

Introduction The UK government defines SMEs as companies with fewer than 250 employees and an annual turnover of less than €50 million. Microbusinesses are those with fewer than 10 employees and an annual turnover of less than €2 million. Small businesses have fewer than 50 employees and an annual turnover of less than €10 million. … Continue reading Protection of Small and Medium Enterprises in UK

Regulations on OTT Platforms-A perplexity

28th September, 2022 - 9:19 am Categories: Social Media

0 Comments

Law is a dynamic field. With new inventions and developments, society evolves and so does the law. Nobody could have predicted the existence of the internet back in the 1950s. However, there are currently 692 million active internet users in India. According to the IAMAI report titled “Internet in India”, there will be 900 million … Continue reading Regulations on OTT Platforms-A perplexity

MoU Signed Between Jawaharlal Nehru Technological University Hyderabad And CII To Create IP Eco-System university.

5th June, 2019 - 10:37 am Categories: Legal Issues

0 Comments

INTRODUCTION Jawaharlal Nehru Technological University Hyderabad and Confederation of Indian Industry (CII) have signed a Memorandum of Understanding (MOU) to create IP eco-system of the university. The Confederation of Indian Industry (CII) works to create and sustain an environment conducive to the development of India, partnering industry, Government, and civil society. CII is a non-government, … Continue reading MoU Signed Between Jawaharlal Nehru Technological University Hyderabad And CII To Create IP Eco-System university.

CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

17th December, 2014 - 8:25 am Categories: India IP Litigation IP Practice in India News & Updates Patent Litigation Patents pharma Pharma/Biotech Patent Litigations

0 Comments

As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s plea here. Background: Cipla, previously approached the Department of Industrial Policy and Promotion (DIPP) to … Continue reading CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

1st November, 2014 - 5:27 pm Categories: India IP Litigation IP Practice in India News & Updates Patent Litigation Patents pharma Pharma/Biotech Patent Litigations

0 Comments

It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy & Promotion) seeking revocation of five patents of Novartis on indacaterol, a respiratory drug for the treatment of chronic obstructive pulmonary disease (COPD) and marketed as Onbrez by Novartis. The central government, under section 66 … Continue reading Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

Tag: government

Protection of Small and Medium Enterprises in UK

Regulations on OTT Platforms-A perplexity

MoU Signed Between Jawaharlal Nehru Technological University Hyderabad And CII To Create IP Eco-System university.

CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

Categories

Archives